Lemonade, Inc. LMND
44.93
(0.35)
(0.77%)
as of 25 Sep
- Market cap
- $3.5B
- P/E
- 0.0×
Follow LMND
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (26.96%) | (26.12%) | (29.37%) | (31.34%) |
+8 more TTM periods Free account |
|
| (7.01%) | (7.28%) | (8.77%) | (9.29%) | ||
ROIC |
(25.59%) | (26.94%) | (34.10%) | (37.14%) | |
Return on Tangible Assets |
65.56% | 85.95% | 124.91% | 109.10% | |
Average Days of Receivables |
233.04 | 256.93 | 274.88 | 312.02 | |
Free Cash Flow per Share |
0.11 | 0.26 | (0.35) | (0.44) | |
Free Cash Flow |
8.10 | 19.50 | (25.90) | (32.90) | |
Capital Expenditures |
(13.10) | (10.60) | (9.40) | (9.50) | |
Piotroski F-Score |
5.00 | 6.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
1.95% | 2.78% | (1.52%) | (2.32%) | |
Accounts Receivable Turnover |
1.70 | 1.54 | 1.44 | 1.25 | |
Accounts Payable Turnover |
0.48 | 0.43 | 0.39 | 0.35 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
794.73 | 905.61 | 991.60 | 1,104.84 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.04 | 0.04 | 0.03 | (0.02) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
44.46% | 46.57% | 49.36% | 51.34% | |
Share Based Compensation of Revenue |
8.34% | 8.55% | 8.31% | 9.13% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.15) | (0.22) | 0.10 | 0.13 | |
Depreciation/Fixed assets |
0.31 | 0.47 | 0.59 | 0.74 | |
Capex/Depreciation |
(2.22) | (1.36) | (1.00) | (0.84) | |
Revenue per Share |
12.67 | 11.07 | 9.98 | 8.88 | |
Operating CF per Share |
0.28 | 0.39 | (0.22) | (0.32) | |
Capex per Share |
(0.17) | (0.14) | (0.13) | (0.13) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(14.19%) | (16.44%) | (22.43%) | (26.39%) |
Columns are period end dates